Prof. Risbridger is a Distinguished Professor at Monash University and expert in Men’s Health and prostate cancer. Her research programs contribute to global efforts to improve preclinical outcomes that more accurately predict patient responses to new therapies and to better inform clinical trial design. Her team has produced one of the largest cohorts of advanced prostate cancer models by involving prostate cancer patients who donate tissue, treating surgeons, oncologists, pathologists, and laboratory researchers. Not only has her program advanced new therapies into clinical trial, but her discoveries have changed guidelines that have been adopted and implemented into Urology, Oncology and Pathology practice in Australia and worldwide. Expertcape’s PubMed-based algorithms placed her in top 1% of scholars on Prostatic Neoplasms in past 10 years. Her exceptional professional contributions were recognized by Fulbright Senior Scholar Award (2001), 4 NH&MRC Research Fellowships (1996-2021), ESA Lifetime Achievement and Senior Plenary Awards (2008 & 2012). In 2022, ESA established the Gail Risbridger Junior Scientist Prize to honour her contribution to basic science and is the only Society award (of six) named for a woman or living person. She is an elected Fellow of Society of Reproductive Biology (2015) and of the Australian Academy of Health and Medical Science (2019). She serves on Cancer Council Victoria's and Australia's Boards, aligning with a mission to support families with cancer in the development of supportive care programs, National Awareness Campaigns as well as research. She proudly mentors within and outside the Biomedical Discovery Institute at Monash University.